ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQHealthcareBiotechnologyUS
USD1.51
-0.06 (-3.82%)
Rating:B-
Company Profile
CEO
Peter Blume-Jensen
IPO Date
2022-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.55
Prev. Close
$1.57
Day Low
$1.51
Day High
$1.60
52W Low
$1.15
52W High
$3.56
Market Cap
$0.05B
Volume
0.29M